Clinical Trial Update: Naloxegol in Cancer Opioid-Induced Constipation [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for naloxegol in cancer opioid-induced constipation has been terminated with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Constipation

Drugs mentioned

• Naloxegol (naloxegol)

Snippet

Sponsor: Joseph Ma | Conditions: Constipation | Phase 2 | Status: TERMINATED | Results posted: 2019-09-04